Enzon Pharmaceuticals Inc. announced that a stockholder meeting was held on February 11, 2026. Stockholders approved an amendment to the company's certificate of incorporation to effect a 1-for-100 reverse stock split of its common stock. Stockholders also approved the adoption of the Agreement and Plan of Merger with Viskase Companies, Inc. and EPSC Acquisition Corp., as amended.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enzon Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-013506), on February 11, 2026, and is solely responsible for the information contained therein.